These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8603530)

  • 1. Influence of the mouse Bcg, Tbc-1 and xid genes on resistance and immune responses to tuberculosis infection and efficacy of bacille Calmette-Guérin (BCG) vaccination.
    Nikonenko BV; Apt AS; Mezhlumova MB; Avdienko VG; Yeremeev VV; Moroz AM
    Clin Exp Immunol; 1996 Apr; 104(1):37-43. PubMed ID: 8603530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct H-2 complex control of mortality, and immune responses to tuberculosis infection in virgin and BCG-vaccinated mice.
    Apt AS; Avdienko VG; Nikonenko BV; Kramnik IB; Moroz AM; Skamene E
    Clin Exp Immunol; 1993 Nov; 94(2):322-9. PubMed ID: 8222323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV].
    Nikonenko BV; Mezhlumova MB; Moroz AM
    Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis.
    Medina E; North RJ
    J Exp Med; 1996 Mar; 183(3):1045-51. PubMed ID: 8642246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
    Ladel CH; Daugelat S; Kaufmann SH
    Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
    Kramnik I; Radzioch D; Skamene E
    Immunology; 1994 Apr; 81(4):618-25. PubMed ID: 8039813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraduodenal vaccination of brushtail possums with bacille Calmette-Guérin enhances immune responses and protection against Mycobacterium bovis infection.
    Buddle BM; Aldwell FE; Keen DL; Parlane NA; Yates G; de Lisle GW
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):377-83. PubMed ID: 9432396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice that carry the resistance allele of the Bcg gene (Bcgr) develop a superior capacity to stabilize bacille Calmette-Guerin (BCG) infection in their lungs and spleen over a protracted period in the absence of specific immunity.
    Medina E; North RJ
    Clin Exp Immunol; 1996 Apr; 104(1):44-7. PubMed ID: 8603532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological memory in CBA and CBA/N mice after vaccination with Mycobacterium bovis (BCG).
    Nikonenko BV; Khaidukov SV; Litvinov IS; Bocharova ; Apt AS
    Bull Exp Biol Med; 2001 Jun; 131(6):548-9. PubMed ID: 11586403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic aspects of BCG vaccination in experimental tuberculosis].
    Nikonenko BV; Apt AS; Mezhlumova MV; Pospelov LE; Moroz AM
    Vestn Ross Akad Med Nauk; 1995; (7):24-8. PubMed ID: 7670336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.
    Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H
    BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses of white-tailed deer (Odocoileus virginianus) to Mycobacterium bovis BCG vaccination.
    Waters WR; Palmer MV; Whipple DL; Slaughter RE; Jones SL
    J Wildl Dis; 2004 Jan; 40(1):66-78. PubMed ID: 15137490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal bacille Calmette-Guerin (BCG) vaccine dosage needs balancing between protection and lung pathology.
    Tree JA; Williams A; Clark S; Hall G; Marsh PD; Ivanyi J
    Clin Exp Immunol; 2004 Dec; 138(3):405-9. PubMed ID: 15544615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
    Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
    Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of high and low antibody responder lines of mice to the growth of avirulent (BCG) and virulent (H37Rv) strains of mycobacteria.
    Gheorghiu M; Mouton D; Lecoeur H; Lagranderie M; Mevel JC; Biozzi G
    Clin Exp Immunol; 1985 Jan; 59(1):177-84. PubMed ID: 3882283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.